Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
Apply
Rilvegostomig vs. Durvalumab
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step